aTyr Pharma, Inc. (ATYR) vs Cel-Sci Corporation (CVM)

aTyr Pharma, Inc. and Cel-Sci Corporation are both Biotechnology companies. aTyr Pharma, Inc. and Cel-Sci Corporation are of similar size ($31.4M and $30.3M). Cel-Sci Corporation grew revenue faster over the last twelve months: 20.8% against 6.78%. Across the 15 metrics below, aTyr Pharma, Inc. leads on 9 and Cel-Sci Corporation on 6.

Valuation

Metric ATYR CVM Biotechnology median
P/E n/m n/m 7.88
P/S 2.64 36.22 11.47
P/B 0.61 1.85 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.42 n/m 0.74
EV/Sales (2.39) 34.83 10.73
Earnings yield (206.67%) (68.40%) (28.84%)
Free cash flow yield (186.29%) (83.02%) (23.03%)

Profitability

Metric ATYR CVM Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (252.53%) (57.72%)
Return on assets (70.97%) (108.91%) (49.22%)
Return on invested capital 0.00% (169.59%) 0.00%

Growth

Metric ATYR CVM Biotechnology median
Revenue growth (TTM) 6.78% 20.75% 5.64%
EPS growth (last fiscal year) 6.98% 59.06% —
Revenue growth, 5-year CAGR (14.75%) 16.18% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR CVM Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 5.12 1.48 4.73
Net debt to EBITDA 1.01 0.25 0.96

Dividend

Metric ATYR CVM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATYR CVM Biotechnology median
Market cap 31.38m 30.25m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack